Kestra Medical CFO Vaseem Mahboob sells $418,217 in shares

In July 30 to August 3, 2026, Kestra Medical Technologies' CFO Vaseem Mahboob sold 18,188 common shares totaling $418,217 across three transactions. The shares were sold at varying prices ranging from $22.6091 to $23.8012 per share. On July 30, Mahboob sold 3,980 shares at a weighted average price of $22.7539, followed by an additional 8,817 shares on July 31 at a weighted average price of $22.6091.

The final reported transaction was the sale of 5,391 shares on August 3 at a weighted average price of $23.8012. These sales were necessary to satisfy tax withholding obligations related to the vesting and settlement of restricted stock units. Kestra Medical's stock has since surged to $28.02, reflecting a 74.6% return over the past year despite the company remaining unprofitable and having a market capitalization of $1.63 billion.

Post-transaction, Mahboob has a direct beneficial ownership of 93,891 common shares in the company. According to InvestingPro analysis, Kestra Medical's stock is currently trading near its 52-week high of $30.00, with the platform's Fair Value assessment indicating potential overvaluation at current levels. Investors are encouraged to explore InvestingPro's 10 additional exclusive tips and comprehensive Pro Research Reports on Kestra Medical Technologies and 1,400+ other US equities.